home All News open_in_new Full Article

European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy

BAAR, Switzerland — Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® (defatted powder of Arachis hypogaea L., semen (peanut)) for the treatment of toddlers (ages 1 through 3) with a confirmed diagnosis of peanut allergy. The marketing authorisation covers […]


today 19 hours ago attach_file Economics
attach_file Other
attach_file Politics
attach_file Economics
attach_file Sport
attach_file Events
attach_file Culture
attach_file Other
attach_file Politics
attach_file Economics
attach_file Sport
attach_file Events
attach_file Other
attach_file Politics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Events


ID: 15487154
Add Watch Country

arrow_drop_down